期刊文献+

抗凝药物的临床应用及安全性评价 被引量:2

Evaluation of Clinical Usage and Safety of Anticoagulant
下载PDF
导出
摘要 目的 :评价抗凝药物肝素和维生素K拮抗剂的临床应用及安全性。方法 :查阅国内外近期相关文献进行综述。结果与结论 :临床上多种血栓栓塞、缺血性疾病中应用肝素、维生素K拮抗剂等抗凝药物时 ,应注意根据患者个体情况 ,掌握剂量 。 OBJECTIVE:To evaluate clinical usage and safe ty of an ticoagulant Heparin and vitamin K antagon.METHODS:To look up recent litera tures at home and abroad for reviewing.RESULTS & CONCLUSION:When using antico agulants,s uch as Heparin and vitamin K antagon for the treatment of multi-thromboembolism and ischemic diseases,we should depend on body condition of cach patient,control the dosage and prevent from various adverse reactions which possibly occur.
出处 《中国医院用药评价与分析》 2003年第6期330-333,共4页 Evaluation and Analysis of Drug-use in Hospitals of China
  • 相关文献

参考文献9

  • 1王振义,李家增,阮长耿主编.血栓与止血基础与临床[M].第2版.上海:上海科学技术出版社,1996:80~90、396~423.
  • 2Moll S, Roberts HR. Overview of anticoagulant drugs for the future[J]. Semin Hemato1, 2002 , 39 ( 3 ) :145.
  • 3Kaplan KL, Francis CW. Direct thrombin inhibitors[ J]. Semin Hematol,2002,39(3): 187.
  • 4Hoppensteadt D, Walenga JM, Fareed J, et al. Heparin, lowmolecuular - weight heparins, and heparin pentasaccharide, basic and clinical differentiation [ J ]. Hematol Oncol Clin N Am,2003,17(1) :313.
  • 5O Shea SI, Ortel TL. Issues in the utilization of low molecular weight heparins[ J]. Semin Hematol,2002,39(3) :172.
  • 6Turpie AGG. Pentasaccharides [ J ]. Semin Hematol, 2002, 39(3):158.
  • 7Bick RL. Heparin - induced thrombocytopenia, paradoxical thromboembolism, and other adverse effects of heparin - type therapy[J]. Hematol Oncol Clin N Am ,2003,17( 1 ) :259.
  • 8Pineo G, Hull RD. Coumarin therapy in thrombosis[ J ]. Hematol Oncol Clin N Am ,2003,17( 1 ) :201.
  • 9Chai SJ, Macik BG. Improving the safety profile of warfarin [J]. Semin Hematol,2002,39(3): 179.

同被引文献14

引证文献2

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部